Zänker KS - Search Results

1

Predictive laboratory diagnostics in oncology utilizing blood-borne cancer cells--current best practice and unmet needs.

Brandt BH, Schmidt H, de Angelis G, Zänker KS. Brandt BH, et al. Among authors: zanker ks. Cancer Lett. 2001 Jan;162 Suppl:S11-S16. doi: 10.1016/s0304-3835(00)00642-x. Cancer Lett. 2001. PMID: 11164185

2

Detection of the metastatic potential of blood-borne and immunomagnetically enriched epithelial cells by quantitative erbB-2 RT-PCR.

Brandt B, Griwatz C, Heidl S, Assmann G, Zänker KS. Brandt B, et al. Among authors: zanker ks. Clin Exp Metastasis. 1996 Sep;14(4):399-408. doi: 10.1007/BF00123399. Clin Exp Metastasis. 1996. PMID: 8878414

3

Translational research studies of erbB oncogenes: selection strategies for breast cancer treatment.

Brandt BH, Beckmann A, Gebhardt F, Rötger A, Jackisch C, Assmann G, Zänker KS. Brandt BH, et al. Among authors: zanker ks. Cancer Lett. 1997 Oct 14;118(2):143-51. doi: 10.1016/s0304-3835(97)00324-8. Cancer Lett. 1997. PMID: 9459204

4

Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients.

Brandt B, Roetger A, Heidl S, Jackisch C, Lelle RJ, Assmann G, Zänker KS. Brandt B, et al. Among authors: zanker ks. Int J Cancer. 1998 Jun 10;76(6):824-8. doi: 10.1002/(sici)1097-0215(19980610)76:6<824::aid-ijc10>3.0.co;2-2. Int J Cancer. 1998. PMID: 9626348

5

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.

Wülfing P, Borchard J, Buerger H, Heidl S, Zänker KS, Kiesel L, Brandt B. Wülfing P, et al. Among authors: zanker ks. Clin Cancer Res. 2006 Mar 15;12(6):1715-20. doi: 10.1158/1078-0432.CCR-05-2087. Clin Cancer Res. 2006. PMID: 16551854

6

Antitumour effects of PLC-gamma1-(SH2)2-TAT fusion proteins on EGFR/c-erbB-2-positive breast cancer cells.

Katterle Y, Brandt BH, Dowdy SF, Niggemann B, Zänker KS, Dittmar T. Katterle Y, et al. Among authors: zanker ks. Br J Cancer. 2004 Jan 12;90(1):230-5. doi: 10.1038/sj.bjc.6601506. Br J Cancer. 2004. PMID: 14710234 Free PMC article.

7

An immunological enrichment method for epithelial cells from peripheral blood.

Griwatz C, Brandt B, Assmann G, Zänker KS. Griwatz C, et al. Among authors: zanker ks. J Immunol Methods. 1995 Jun 28;183(2):251-65. doi: 10.1016/0022-1759(95)00063-g. J Immunol Methods. 1995. PMID: 7602148

8

Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissues and comparison to cellular DNA content.

Brandt B, Vogt U, Harms F, Bosse U, Zänker KS, Assmann G. Brandt B, et al. Among authors: zanker ks. Gene. 1995 Jun 14;159(1):29-34. doi: 10.1016/0378-1119(94)00651-8. Gene. 1995. PMID: 7607569

9

Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis.

Brandt B, Vogt U, Schlotter CM, Jackisch C, Werkmeister R, Thomas M, von Eiff M, Bosse U, Assmann G, Zänker KS. Brandt B, et al. Among authors: zanker ks. Gene. 1995 Jun 14;159(1):35-42. doi: 10.1016/0378-1119(94)00652-9. Gene. 1995. PMID: 7607571

10

Isolation of prostate-derived single cells and cell clusters from human peripheral blood.

Brandt B, Junker R, Griwatz C, Heidl S, Brinkmann O, Semjonow A, Assmann G, Zänker KS. Brandt B, et al. Among authors: zanker ks. Cancer Res. 1996 Oct 15;56(20):4556-61. Cancer Res. 1996. PMID: 8840959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters